St. Johns Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

St. Johns Investment Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$66.4K	Hold	86	–	–	0.03%	100
2025 Q4	$66.4K	Hold	86	–	–	0.03%	98
2025 Q3	$48.4K	Hold	86	–	–	0.02%	102
2025 Q2	$45.1K	Hold	86	–	–	0.02%	105
2025 Q1	$54.5K	Hold	86	–	–	0.03%	100
2024 Q4	$61.3K	Hold	86	–	–	0.03%	103
2024 Q3	$90.4K	Hold	86	–	–	0.04%	96
2024 Q2	$90.4K	Hold	86	–	–	0.04%	96
2024 Q1	$82.8K	Hold	86	–	–	0.04%	102
2023 Q4	$75.5K	Hold	86	–	–	0.04%	98
2023 Q3	$70.8K	Hold	86	–	–	0.04%	97
2023 Q2	$61.8K	Hold	86	–	–	0.03%	98
2023 Q1	$70.7K	Hold	86	–	–	0.04%	99
2022 Q4	$62K	Hold	86	–	–	0.04%	99
2022 Q3	$59K	Hold	86	–	–	0.04%	102
2022 Q2	$51K	Hold	86	–	–	0.03%	101
2022 Q1	$60K	Hold	86	–	–	0.03%	103
2021 Q4	$54K	Hold	86	–	–	0.03%	98
2021 Q3	$52K	Hold	86	–	–	0.03%	99
2021 Q2	$48K	Hold	86	–	–	0.03%	93
2021 Q1	$41K	Hold	86	–	–	0.02%	94
2020 Q4	$42K	Hold	86	–	–	0.03%	96
2020 Q3	$48K	Hold	86	–	–	0.03%	92
2020 Q2	$54K	Hold	86	–	–	0.04%	93
2020 Q1	$42K	Hold	86	–	–	0.04%	89
2019 Q4	$32K	Hold	86	–	–	0.02%	98
2019 Q3	$24K	Hold	86	–	–	0.02%	104
2019 Q2	$27K	Hold	86	–	–	0.02%	102
2019 Q1	$35K	Hold	86	–	–	0.03%	104
2018 Q4	$32K	Hold	86	–	–	0.03%	101
2018 Q3	$35K	Hold	86	–	–	0.03%	110
2018 Q2	$30K	Hold	86	–	–	0.02%	118
2018 Q1	$30K	Hold	86	–	–	0.02%	118
2017 Q4	$32K	Hold	86	–	–	0.02%	104
2017 Q3	$38K	Hold	86	–	–	0.03%	123
2017 Q2	$42K	Sell	86 -4	-4%	-$1.75K	0.03%	109
2017 Q1	$35K	Hold	90	–	–	0.03%	101
2016 Q4	$33K	Hold	90	–	–	0.03%	103
2016 Q3	$36K	Hold	90	–	–	0.03%	99
2016 Q2	$31K	Hold	90	–	–	0.03%	101
2016 Q1	$32K	Hold	90	–	–	0.03%	99
2015 Q4	$49K	Hold	90	–	–	0.04%	92
2015 Q3	$42K	Hold	90	–	–	0.04%	94
2015 Q2	$46K	Hold	90	–	–	0.04%	92
2015 Q1	$41K	Sell	90 -10	-10%	-$4.24K	0.04%	90
2014 Q4	$41K	Hold	100	–	–	0.04%	91
2014 Q3	$36K	Sell	100 -26	-21%	-$8.71K	0.03%	87
2014 Q2	$36K	Buy	126 +26	+26%	+$7.71K	0.03%	90
2014 Q1	$30K	Buy	+100	New	+$30.8K	0.03%	90

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

St. Johns Investment Management's REGN Position: Q1 2026 in Review

St. Johns Investment Management held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 86 shares worth $66.4K. The position accounts for 0.03% of the portfolio, ranked #100.

St. Johns Investment Management first reported a position in REGN in Q1 2014 and has held it in 49 quarters since. The position peaked at $90.4K in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

St. Johns Investment Management held 86 shares of Regeneron Pharmaceuticals worth $66.4K as of Q1 2026.
St. Johns Investment Management left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
Regeneron Pharmaceuticals made up 0.03% of St. Johns Investment Management's portfolio in Q1 2026, its #100 holding.
St. Johns Investment Management first reported a position in Regeneron Pharmaceuticals in Q1 2014 and has held it in 49 quarters since.
St. Johns Investment Management's Regeneron Pharmaceuticals position peaked at $90.4K in Q3 2024.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on St. Johns Investment Management's 13F filing for Q1 2026, filed 28 Apr 2026.